Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 96.11M | 95.74M | 94.61M | 88.42M | 82.87M |
Gross Profit | 96.11M | 95.74M | 94.61M | 88.42M | 82.87M |
EBITDA | 0.00 | 34.30M | 39.91M | 37.26M | 28.13M |
Net Income | 23.67M | 25.00M | 28.78M | 26.43M | 19.26M |
Balance Sheet | |||||
Total Assets | 2.78B | 2.71B | 2.65B | 2.42B | 2.28B |
Cash, Cash Equivalents and Short-Term Investments | 591.64M | 630.17M | 688.46M | 819.01M | 663.15M |
Total Debt | 118.52M | 40.80M | 201.57M | 25.86M | 11.11M |
Total Liabilities | 2.56B | 2.52B | 2.48B | 2.21B | 2.08B |
Stockholders Equity | 215.31M | 195.24M | 166.39M | 211.46M | 199.70M |
Cash Flow | |||||
Free Cash Flow | 26.19M | 30.42M | 34.62M | 35.09M | 27.79M |
Operating Cash Flow | 29.82M | 30.88M | 35.05M | 35.46M | 28.66M |
Investing Cash Flow | -57.72M | -82.38M | -252.62M | -242.48M | -495.85M |
Financing Cash Flow | 38.10M | 32.48M | 246.46M | 125.47M | 453.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $249.22M | 15.41 | 7.72% | 2.72% | 8.36% | -2.51% | |
78 Outperform | $215.63M | 13.33 | 6.54% | 5.78% | 24.45% | 25.55% | |
71 Outperform | $239.06M | 10.53 | 10.65% | 2.56% | 6.05% | -9.27% | |
70 Outperform | $241.07M | 11.34 | 10.50% | 4.04% | 14.11% | 29.41% | |
61 Neutral | C$14.56B | 6.16 | 20.17% | 5.70% | 26.93% | -38.21% | |
60 Neutral | $220.08M | 18.32 | 6.62% | 3.34% | -6.85% | -51.70% | |
56 Neutral | $272.94M | 68.83 | 1.06% | 3.62% | 5.36% | ― |
Chemung Financial Corporation announced the completion of a strategic balance sheet repositioning by selling securities worth approximately $242 million, resulting in a pre-tax loss of $17 million to be recognized in the second quarter of 2025. The proceeds will be used to reduce non-core funding liabilities and support loan growth, with expectations of improved financial metrics from the third quarter of 2025, despite reporting a net loss for the second quarter.
The most recent analyst rating on (CHMG) stock is a Hold with a $57.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.
On June 10, 2025, Chemung Financial Corporation issued $45 million in subordinated notes due 2035 to accredited investors and institutional buyers. This move aims to support the company’s growth initiatives and regulatory capital ratios, potentially involving balance sheet restructuring. The notes, maturing in 2035, will initially bear a fixed interest rate of 7.75% until 2030, after which they will switch to a floating rate. This strategic financial maneuver is expected to enhance Chemung’s capital structure and support its expansion efforts.
The most recent analyst rating on (CHMG) stock is a Hold with a $57.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.
At the Annual Meeting of Shareholders on June 3, 2025, Chemung Financial Corporation shareholders voted on four proposals. The election of directors resulted in the appointment of Ronald M. Bentley, David M. Buicko, Robert H. Dalrymple, and Jeffrey B. Streeter for three-year terms. Additionally, the shareholders approved the compensation for the Corporation’s Named Executive Officers, the 2025 Equity Incentive Plan, and ratified the appointment of Crowe LLP as the independent registered public accounting firm for the year ending December 31, 2025.
The most recent analyst rating on (CHMG) stock is a Hold with a $57.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.
On May 22, 2025, Chemung Financial Corporation announced a quarterly cash dividend of $0.32 per share, payable on July 1, 2025, to shareholders of record as of June 17, 2025. This decision reflects the company’s ongoing commitment to providing value to its shareholders and may positively impact its market positioning by reinforcing investor confidence.
The most recent analyst rating on (CHMG) stock is a Hold with a $57.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.